Alice S Mims, MD
Ohio State University Comprehensive Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alice S Mims, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:24 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05401097 · IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)Alice Mims · recruiting · Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AMLR01CA262496 · NCI · OHIO STATE UNIVERSITY · PI Ann-Kathrin Eisfeld, Elaine R. Mardis, Alice Scott Mims · fiscal years 2022 to 2026Named on NCT05401097
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.